Clinical Study

Outcomes of Six-Dose High-Dose Cytarabine as a Salvage Regimen for Patients with Relapsed/Refractory Acute Myeloid Leukemia

Table 3

Nonhematological adverse events.

ToxicityNumber of patients (%)

Liver toxicity (Grade 2)1 (4)

Mucositis
 (i) Grade 1 (mild)1 (4)
 (ii) Grade ≥ 2 (moderate-severe)2 (8)

Cerebellar toxicity2 (8)

Neutropenic fever10 (38)

Infection
 (i) Fungal pneumonia4 (15)
 (ii) Pneumonia, unknown pathogen1 (4)
 (iii) Bacteremia4 (15)
 (iv) Cellulitis1 (4)

Skin toxicity2 (8)

Other toxicities: nausea (1) and pericardial effusion (n = 1)